Alfa Rhythm
Electro-biometric Stimulator for Depression, Anxiety, and Sleep Disorders
Company Overview
Snapshot
Founded in February 2014 by Khaled Khalil, Alfa Rhythm is a Health Tech & Life Sciences company with 1–10 employees. The company was acquired by Generex Biotechnology in October 2015.
Business overview
Alfa Rhythm develops a unique electro-biometric stimulator designed to balance brain frequencies. Its core product, the Alfa Rhythm watch, uses externally programmed vibrations to generate waveforms and dominant frequencies, aiding in the regulation and synchronization of brainwave activity. This non-invasive technology is intended to treat conditions such as ADD/ADHD, stress, depression, anxiety, headaches, insomnia, Alzheimer’s, Parkinson’s, and epilepsy, serving patients in the healthcare sector.
Strategic signal
In October 2015, Alfa Rhythm was acquired by Generex Biotechnology. This acquisition signaled a strategic move by Generex Biotechnology to integrate Alfa Rhythm's electro-biometric stimulation technology, indicating a market validation for non-invasive brain stimulation devices in addressing various neurological and mental health conditions.
Log in to access full profile ›Company Intelligence Q&A
- What is Alfa Rhythm's primary product?
- Alfa Rhythm's primary product is the Alfa Watch, an electro-biometric stimulator designed to balance brain frequencies and aid in changing brainwaves.
- When was Alfa Rhythm founded?
- Alfa Rhythm was founded in February 2014.
- What conditions does Alfa Rhythm's technology aim to treat?
- Alfa Rhythm's devices are made to treat complications with ADD/ADHD, stress, depression, anxiety, headaches, insomnia, Alzheimer’s, Parkinson’s, and epilepsy.
- Who acquired Alfa Rhythm?
- Alfa Rhythm was acquired by Generex Biotechnology in October 2015.
- Who is a co-founder of Alfa Rhythm?
- Khaled Khalil is a co-founder of Alfa Rhythm, also serving as EVP R&D and Chairman.